Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

OBJECTIVE: To compare the characteristics and outcomes of patients with atrial fibrillation (AF) and aortic stenosis (AS) with patients with AF with mitral regurgitation (MR) or aortic regurgitation (AR) and patients without significant valve disease (no SVD). METHODS: Using Rivaroxaban Once-Daily,...

Descripción completa

Detalles Bibliográficos
Autores principales: Breithardt, Günter, Baumgartner, Helmut, Berkowitz, Scott D, Hellkamp, Anne S, Piccini, Jonathan P, Lokhnygina, Yuliya, Halperin, Jonathan L, Singer, Daniel E, Hankey, Graeme J, Hacke, Werner, Becker, Richard C, Nessel, Christopher C, Mahaffey, Kenneth W, Califf, Robert M, Fox, Keith A A, Patel, Manesh R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Valvular Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941167/
https://www.ncbi.nlm.nih.gov/pubmed/26888572
http://dx.doi.org/10.1136/heartjnl-2015-308120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941167/
https://www.ncbi.nlm.nih.gov/pubmed/26888572
http://dx.doi.org/10.1136/heartjnl-2015-308120

Ejemplares similares